(UVV) Universal - Overview
Stock: Leaf Tobacco, Ingredients, Extracts, Concentrates, Flavors
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.12% |
| Yield on Cost 5y | 9.02% |
| Yield CAGR 5y | 1.27% |
| Payout Consistency | 98.5% |
| Payout Ratio | 50.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | 13.29 |
| Character TTM | |
|---|---|
| Beta | 0.155 |
| Beta Downside | 0.224 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.70% |
| CAGR/Max DD | 0.34 |
Description: UVV Universal January 16, 2026
Universal Corporation (NYSE:UVV) is a B2B agriproducts firm that supplies leaf tobacco and a broad portfolio of plant-based ingredients to food, beverage, and consumer-packaged-goods manufacturers worldwide.
The company operates two distinct segments. The Tobacco Operations segment purchases, processes, packs, stores, and ships various tobacco leaf types (flue-cured, burley, dark air-cured, oriental) and offers ancillary services such as custom blending, chemical/physical testing, reconstituted leaf manufacturing, just-in-time delivery, liquid nicotine, and recycling of tobacco waste. The Ingredients Operations segment produces specialty plant-derived products-including fruit and vegetable juices, concentrates, purees, nutraceuticals, seed powders, botanical extracts, natural flavors, and colors-for food, beverage, and flavor companies.
Key metrics (FY 2023): revenue of ≈ $2.1 bn, EBITDA margin of ≈ 13%, and a net debt-to-EBITDA ratio of ~ 2.2×, reflecting a balance between cash-generating tobacco assets and growth-oriented ingredient operations.
Sector drivers: (1) Declining global cigarette consumption-down ~2% YoY-pressures tobacco leaf demand, but UVV’s diversified ingredient business offsets this trend. (2) Rising consumer demand for clean-label and plant-based ingredients, projected to grow at a 7% CAGR through 2028, underpins the Ingredients segment’s growth outlook. (3) Commodity price volatility (e.g., tobacco leaf, corn, soy) directly impacts cost structures, making hedging and supply-chain resilience critical.
Founded in 1886 and headquartered in Richmond, Virginia, UVV leverages its long-standing relationships with growers and manufacturers to capture value across the entire supply chain.
For a deeper quantitative analysis of UVV’s valuation and risk profile, you may find ValueRay’s data tools useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 111.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 11.84 > 1.0 |
| NWC/Revenue: 47.23% < 20% (prev 46.98%; Δ 0.25% < -1%) |
| CFO/TA 0.05 > 3% & CFO 154.6m > Net Income 111.6m |
| Net Debt (1.11b) to EBITDA (189.5m): 5.83 < 3 |
| Current Ratio: 2.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.2m) vs 12m ago 1.87% < -2% |
| Gross Margin: 18.88% > 18% (prev 0.19%; Δ 1869 % > 0.5%) |
| Asset Turnover: 97.69% > 50% (prev 95.23%; Δ 2.47% > 0%) |
| Interest Coverage Ratio: 1.84 > 6 (EBITDA TTM 189.5m / Interest Expense TTM 80.0m) |
Altman Z'' 5.59
| A: 0.46 (Total Current Assets 2.24b - Total Current Liabilities 828.6m) / Total Assets 3.07b |
| B: 0.39 (Retained Earnings 1.19b / Total Assets 3.07b) |
| C: 0.05 (EBIT TTM 147.1m / Avg Total Assets 3.06b) |
| D: 0.94 (Book Value of Equity 1.47b / Total Liabilities 1.57b) |
| Altman-Z'' Score: 5.59 = AAA |
Beneish M -3.01
| DSRI: 1.01 (Receivables 559.3m/537.6m, Revenue 2.99b/2.90b) |
| GMI: 1.02 (GM 18.88% / 19.20%) |
| AQI: 0.98 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.03 (Revenue 2.99b / 2.90b) |
| TATA: -0.01 (NI 111.6m - CFO 154.6m) / TA 3.07b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of UVV shares?
Over the past week, the price has changed by +5.14%, over one month by +12.50%, over three months by +14.33% and over the past year by +18.91%.
Is UVV a buy, sell or hold?
What are the forecasts/targets for the UVV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78 | 32.9% |
| Analysts Target Price | 78 | 32.9% |
| ValueRay Target Price | 66 | 12.5% |
UVV Fundamental Data Overview February 03, 2026
P/S = 0.4721
P/B = 0.946
Revenue TTM = 2.99b USD
EBIT TTM = 147.1m USD
EBITDA TTM = 189.5m USD
Long Term Debt = 618.2m USD (from longTermDebt, last quarter)
Short Term Debt = 551.4m USD (from shortTermDebt, last quarter)
Debt = 1.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b USD (from netDebt column, last quarter)
Enterprise Value = 2.42b USD (1.32b + Debt 1.19b - CCE 88.7m)
Interest Coverage Ratio = 1.84 (Ebit TTM 147.1m / Interest Expense TTM 80.0m)
EV/FCF = 15.43x (Enterprise Value 2.42b / FCF TTM 157.1m)
FCF Yield = 6.48% (FCF TTM 157.1m / Enterprise Value 2.42b)
FCF Margin = 5.26% (FCF TTM 157.1m / Revenue TTM 2.99b)
Net Margin = 3.74% (Net Income TTM 111.6m / Revenue TTM 2.99b)
Gross Margin = 18.88% ((Revenue TTM 2.99b - Cost of Revenue TTM 2.42b) / Revenue TTM)
Gross Margin QoQ = 18.54% (prev 19.19%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.42b / Total Assets 3.07b)
Interest Expense / Debt = 1.83% (Interest Expense 21.8m / Debt 1.19b)
Taxrate = 24.36% (11.2m / 46.0m)
NOPAT = 111.3m (EBIT 147.1m * (1 - 24.36%))
Current Ratio = 2.70 (Total Current Assets 2.24b / Total Current Liabilities 828.6m)
Debt / Equity = 0.81 (Debt 1.19b / totalStockholderEquity, last quarter 1.47b)
Debt / EBITDA = 5.83 (Net Debt 1.11b / EBITDA 189.5m)
Debt / FCF = 7.04 (Net Debt 1.11b / FCF TTM 157.1m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.65% (Net Income 111.6m / Total Assets 3.07b)
RoE = 7.65% (Net Income TTM 111.6m / Total Stockholder Equity 1.46b)
RoCE = 7.08% (EBIT 147.1m / Capital Employed (Equity 1.46b + L.T.Debt 618.2m))
RoIC = 4.25% (NOPAT 111.3m / Invested Capital 2.62b)
WACC = 4.06% (E(1.32b)/V(2.51b) * Re(6.49%) + D(1.19b)/V(2.51b) * Rd(1.83%) * (1-Tc(0.24)))
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.24%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈157.1m ; Y1≈103.1m ; Y5≈47.1m
Fair Price DCF = 15.81 (EV 1.50b - Net Debt 1.11b = Equity 393.9m / Shares 24.9m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 2.69 | EPS CAGR: -39.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 36.24 | Revenue CAGR: 3.93% | SUE: N/A | # QB: 0
EPS next Year (2027-03-31): EPS=4.61 | Chg30d=+0.350 | Revisions Net=+1 | Growth EPS=-1.9% | Growth Revenue=+1.0%